Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells

Molecular Endocrinology

Volumn 17, Issue 5, 2003, Pages 792-803

  Hall, Julie M ^a   Korach, Kenneth S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; PROTEIN SYNTHESIS INHIBITOR; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1BETA;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; OVARY CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; CHEMOKINES, CXC; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MITOGENS; OVARIAN NEOPLASMS; PROTEIN ISOFORMS; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, CXCR4; RECEPTORS, ESTROGEN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0038636392     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0438     Document Type: Article

References (46)

1. Greenlee RT, Murray T, Bolden S, Wingo PA 2000 Cancer statistics, 2000. CA Cancer J Clin 50:7-33
2. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV 2000 Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell Dev Biol Anim 36:657-666
3. Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ 2001 Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 285:1460-1465
4. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Weiderpass E, Persson IR 2002 Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 94:497-504
5. Havrilesky LJ, McMahon CP, Lobenhofer EK, Whitaker R, Marks JR, Berchuck A 2001 Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones. J Soc Gynecol Investig 8:104-113
6. Lindgren P, Backstrom T, Mahlck CG, Ridderheim M, Cajander S 2001 Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors. Int J Oncol 19:31-38
7. Jordan VC, Morrow M 1999 Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 20:253-278
8. Hall JM, Couse JF, Korach KS 2001 The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
9. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, Koehl C, Calderoli H, Schiff V, Renaud R, Chambon P 1987 Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 84:9243-9247
10. Rochefort H 1999 Estrogen-induced genes in breast cancer, and their medical importance. Bull Acad Natl Med 183:955-968
11. Clinton GM, Rougeot C, Derancourt J, Roger P, Defrenne A, Godyna S, Argraves WS, Rochefort H 1996 Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells. Proc Natl Acad Sci USA 93:316-320
12. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
13. Moll F, Katsaros D, Lazennec G, Hellio N, Roger P, Giacalone PL, Chalbos D, Maudelonde T, Rochefort H, Pujol P 2002 Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells. Oncogene 21:1097-1107
14. Geisinger KR, Kute TE, Pettenati MJ, Welander CE, Dennard Y, Collins LA, Berens ME 1989 Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer 63:280-288
15. Schmitt E, Dekant W, Stopper H 2001 Assaying the estrogenicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro 15:433-439
16. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T 1996 Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638
17. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA 1996 The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833
18. Feng Y, Broder CC, Kennedy PE, Berger EA 1996 HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877
19. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B 1996 The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835
20. Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, Curiel TJ 2001 Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7:1339-1346
21. Nishita M, Aizawa H, Mizuno K 2002 Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis. Mol Cell Biol 22:774-783
22. Nagasawa T, Tachibana K, Kishimoto T 1998 A novel CXC chemokine PBSF/SDF-1 and its receptor CXCR4: their functions in development, hematopoiesis and HIV infection. Semin Immunol 10:179-185
23. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A 2001 Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56
24. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjo T 1993 Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261:600-603
25. Nagasawa T, Kikutani H, Kishimoto T 1994 Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 91:2305-2309
26. Pillarisetti K, Gupta SK 2001 Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1): SDF-1α mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25:293-300
27. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hollt V, Schulz S 2002 A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4- dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22:5865-5878
28. Willson TM, Norris JD, Wagner BL, Asplin I, Baer P, Brown HR, Jones SA, Henke B, Sauls H, Wolfe S, Morris DC, McDonnell DP 1997 Dissection of the molecular mechanism of action of GW5638, a novel estrogen receptor ligand, provides insights into the role of ER in bone. Endocrinology 138:3901-3911
29. Brown AM, Jeltsch JM, Roberts M, Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81:6344-6348
30. Ma Q, Renzelli AJ, Baldwin KT, Antonini JM 2000 Super-induction of CYP1A1 gene expression. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. J Biol Chem 275:12676-12683
31. Ly LH, Zhao XY, Holloway L, Feldman D 1999 Liarozole acts synergistically with 1α25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071-2076
32. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M 2000 Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6:3530-3535
33. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman JE 1998 The α-chemokine, stromal cell-derived factor-1α, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273:23169-23175
34. Castoria G, Barone MV, Di Domenico M, Bilancio A, Ametrano D, Migliaccio A, Auricchio F 1999 Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 18:2500-2510
35. Di Salvo J, Koch GE, Johnson KE, Blake AD, Daugherty BL, DeMartino JA, Sirotina-Meisher A, Liu Y, Springer MS, Cascieri MA, Sullivan KA 2000 The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both the Gα(i)-coupled and uncoupled states. Eur J Pharmacol 409:143-154
36. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F 2002 Src is an initial target of sex steroid hormone action. Ann NY Acad Sci 963:185-190
37. Benten WP, Stephan C, Lieberherr M, Wunderlich F 2001 Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677
38. Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R, Franke FE 2000 Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 89:1783-1791
39. Klein RS, Rubin JB, Gibson HD, DeHaan EN, Alvarez-Hernandez X, Segal RA, Luster AD 2001 SDF-1α induces chemotaxis and enhances Sonic hedgehog-induced proliferation of cerebellar granule cells. Development 128:1971-1981
40. Rochefort H, Chalbos D, Cunat S, Lucas A, Platet N, Garcia M 2001 Estrogen regulated proteases and anti-proteases in ovarian and breast cancer cells. J Steroid Biochem Mol Biol 76:119-124
41. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA 1998 Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 95:9448-9453
42. Zhu Y, Yu T, Zhang XC, Nagasawa T, Wu JY, Rao Y 2002 Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci 5:719-720
43. Rochefort H, Platet N, Hayashido Y, Derocq D, Lucas A, Cunat S, Garcia M 1998 Estrogen receptor mediated inhibition of cancer cell invasion and motility: an overview. J Steroid Biochem Mol Biol 65:163-168
44. Lu Q, Sun EE, Klein RS, Flanagan JG 2001 Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105:69-79
45. Ali S, Metzger D, Bornert J-M, Chambon P 1993 Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region. EMBO J 12:1153-1160
46. Schreiber E, Matthias P, Muller MM, Schaffner W 1988 Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J 7:4221-4229